Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
4.485
+0.135 (3.10%)
At close: Jun 26, 2026, 4:00 PM EDT
4.490
+0.005 (0.11%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Atea Pharmaceuticals Employees
Atea Pharmaceuticals had 55 employees as of December 31, 2025. The number of employees decreased by 1 or -1.79% compared to the previous year.
Employees
55
Change (1Y)
-1
Growth (1Y)
-1.79%
Revenue / Employee
n/a
Profits / Employee
-$3,082,127
Market Cap
359.32M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Verastem | 102 |
| Upstream Bio | 75 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 59 |
| X4 Pharmaceuticals | 45 |
| Compass Therapeutics | 39 |
AVIR News
- 2 days ago - Atea Pharmaceuticals completes patient enrollment in C-FORWARD trial - TheFly
- 2 days ago - Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus - GlobeNewsWire
- 9 days ago - Atea Pharmaceuticals Transcript: AGM 2026 - Transcripts
- 4 weeks ago - Atea Pharmaceuticals Presents New Drug-Drug Interaction Results Supporting Potential Best-in-Class Profile of the Regimen of Bemnifosbuvir and Ruzasvir for the Treatment of Hepatitis C Virus at EASL Congress 2026 - GlobeNewsWire
- 6 weeks ago - Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis Pipeline - GlobeNewsWire
- 6 weeks ago - Atea Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 6 weeks ago - Atea Pharmaceuticals Slides: Q1 2026 - Filings
- 6 weeks ago - Atea Pharmaceuticals Earnings release: Q1 2026 - Filings